Clinical Significance of the Presence or Absence of Lipid-Rich Plaque Underneath Intact Fibrous Cap Plaque in Acute Coronary Syndrome.
Acute Coronary Syndrome
/ diagnostic imaging
Aged
Coronary Artery Disease
/ diagnostic imaging
Coronary Vessels
/ diagnostic imaging
Databases, Factual
Female
Fibrosis
Humans
Lipids
/ analysis
Male
Middle Aged
Percutaneous Coronary Intervention
Plaque, Atherosclerotic
Predictive Value of Tests
Retrospective Studies
Risk Factors
Rupture, Spontaneous
Time Factors
Tomography, Optical Coherence
Treatment Outcome
acute coronary syndrome
intact fibrous cap
optical coherence tomography
percutaneous coronary intervention
plaque rupture
Journal
Journal of the American Heart Association
ISSN: 2047-9980
Titre abrégé: J Am Heart Assoc
Pays: England
ID NLM: 101580524
Informations de publication
Date de publication:
07 05 2019
07 05 2019
Historique:
entrez:
7
5
2019
pubmed:
7
5
2019
medline:
4
8
2020
Statut:
ppublish
Résumé
Background Although most coronary thromboses occur on the surface of lipid-rich plaque ( LRP ) with plaque rupture ( PR ), previous pathological and optical coherence tomography studies demonstrated diversity in the morphological characteristics of culprit plaque underlying the thrombus, including lesions with intact fibrous cap ( IFC ). We investigated the clinical significance of IFC in relation to the presence or absence of LRP observed via optical coherence tomography in culprit lesions of acute coronary syndrome. Methods and Results We investigated 510 patients with acute coronary syndrome who underwent optical coherence tomography for the culprit lesion. Optical coherence tomography analysis included the presence or absence of PR , which were categorized into the PR group and the IFC group, respectively. The IFC group was further categorized on the basis of the presence of LRP . Incidence of major adverse cardiac events ( MACEs ), including cardiac death, myocardial infarction, and clinically driven remote revascularizations, was compared. Culprit lesions were categorized into 328 PR s and 182 IFC s. MACEs occurred in 85 patients (16.7%) during the median follow-up duration of 621 days. LRP was detected in 325 lesions (99%) with PR , whereas 60 (33.0%) of the lesions with IFC did not show LRP . Kaplan-Meier analysis revealed significantly lower MACEs in the IFC group compared with the PR group. Furthermore, the IFC group without LRP showed significantly lower MACEs compared with the IFC group with LRP . Multivariate Cox proportional hazards analysis demonstrated that IFC without LRP was an independent predictor of better prognosis. Conclusions Exclusion of LRP underneath IFC culprit lesions in acute coronary syndrome may predict a lower risk of future MACEs .
Identifiants
pubmed: 31057022
doi: 10.1161/JAHA.118.011820
pmc: PMC6512119
doi:
Substances chimiques
Lipids
0
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
e011820Références
Circulation. 2004 Jun 1;109(21):2503-6
pubmed: 15148270
JACC Cardiovasc Imaging. 2013 Aug;6(8):908-16
pubmed: 23850249
Thromb Haemost. 2016 Mar;115(3):509-19
pubmed: 26791872
Int J Cardiol. 2016 Jan 15;203:766-74
pubmed: 26590891
Heart. 2005 Apr;91(4):526-30
pubmed: 15772220
Circulation. 2003 Nov 18;108(20):2473-8
pubmed: 14610010
J Am Coll Cardiol. 2001 Apr;37(5):1271-6
pubmed: 11300434
JAMA Cardiol. 2018 Mar 1;3(3):207-214
pubmed: 29417141
Circulation. 1996 Dec 15;94(12):3098-102
pubmed: 8989115
Eur Heart J. 2015 Jun 7;36(22):1377-84
pubmed: 25713314
J Am Coll Cardiol. 2017 May 23;69(20):2502-2513
pubmed: 28521888
Circulation. 2001 Dec 18;104(25):3103-8
pubmed: 11748108
JACC Cardiovasc Imaging. 2015 May;8(5):566-575
pubmed: 25890582
J Am Coll Cardiol. 2014 Dec 16;64(23):2510-8
pubmed: 25500237
J Am Heart Assoc. 2019 May 7;8(9):e011820
pubmed: 31057022
Am Heart J. 2014 Jan;167(1):59-67
pubmed: 24332143
Eur Heart J. 2011 Nov;32(22):2814-23
pubmed: 21719455
N Engl J Med. 2011 Jan 20;364(3):226-35
pubmed: 21247313
J Am Coll Cardiol. 2004 Sep 1;44(5):972-9
pubmed: 15337206
N Engl J Med. 1997 May 1;336(18):1276-82
pubmed: 9113930
J Am Coll Cardiol. 2013 Nov 5;62(19):1748-58
pubmed: 23810884
Circulation. 1999 Sep 21;100(12):1285-90
pubmed: 10491372
Circulation. 2002 Sep 24;106(13):1640-5
pubmed: 12270856
JACC Cardiovasc Interv. 2016 Oct 10;9(19):2002-2011
pubmed: 27712735
J Am Coll Cardiol. 2006 Apr 18;47(8 Suppl):C13-8
pubmed: 16631505